U.S. Markets closed

Flex Pharma Refocuses Goals for FLX-787 and Develops HOTSHOT Market, Analysts Review

NEW YORK, NY / ACCESSWIRE / October 22, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Flex Pharma, Inc. (FLKS) a biotechnology company focused on developing innovative and proprietary treatments for muscle cramps, spasms, and spasticity associated with severe neurological conditions.

Earlier this year the company stopped its clinical trials of FLX-787 in MND and CMT and is the process of winding down those studies. Management cited the cost of continued clinical trials as the reason.

More about the halt of FLX-787 trials, the analysts' review, and target READ MORE

Copy and paste to your browser may be required to view the report – https://tradersnewssource.com/flex-pharma/

The company will now be focussing their efforts on assessing the potential of FLX-787 in dysphagia (difficulty swallowing) and operating the HOTSHOT consumer business while the strategic review is ongoing.

HOTSHOT™ is the sports shot with a kick that is scientifically proven to prevent and treat muscle cramps. A scientific breakthrough in sports nutrition, HOTSHOT is a proprietary formulation of organic ingredients that boosts Neuro Muscular Performance – how an athlete's nerves and muscles work together optimally.

Financial data, key company statements and a look at recent events in this full report READ MORE

Copy and paste to your browser may be required to view the report – https://tradersnewssource.com/flex-pharma/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: editor@tradersnewssource.com

SOURCE: Traders News Source